Pharmacy Student of the Year finalists head to PSA24

5 July 2024



The Pharmaceutical Society of Australia (PSA) has today announced the finalists for its annual Pharmacy Student of the Year competition who will compete for the top prize at PSA’s national conference PSA24 in August.


The final will test pharmacy students with a real-life clinical situation, where a patient will present with symptoms or a specific medicine or product request. Students are then required to use their clinical knowledge and communication skills to identify the most appropriate management, tailoring their response to provide the patient-centred advice.


A judging panel will assess all state finalists before selecting the national winner to be announced at PSA24’s Gala Dinner.


The 2024 PSA Viatris Pharmacy Student of the Year finalists are:

  • Blake Fraser, University of Technology Sydney (NSW finalist)
  • Emily Schrek, La Trobe University (Victorian finalist)
  • Bridget Cleary, University of Western Australia (WA finalist)
  • Tobey Adubasim, University of Tasmania (Tasmanian finalist)
  • Hayden Scott, University of Canberra (ACT finalist)
  • Shylee-Jade Hadar-Pagliari, James Cook University (Queensland finalist)
  • Callum Gunn, University of South Australia (SA finalist)
  • Lauren Murray, Charles Darwin University (NT finalist)
  • McKinley Nolan, University of Tasmania (NAPSA Wildcard finalist)


PSA National President Associate Professor Fei Sim FPS congratulated the PSOTY competition finalists.


“The Pharmacy Student of the Year competition showcases the talents of the next generation of pharmacists, giving them the opportunity to develop and grow their skills,” Associate Professor Sim said.


“It’s exciting to see such enthusiastic students entering our profession and dedicating their futures to improving the health and wellbeing of our communities.


“Award sponsor Viatris and PSA are proud to sponsor the finalists to attend the PSA24 conference where they will compete in the national finals.


“Congratulations to all the students who’ve participated in the competition this year for their dedication and commitment to pharmacy. Regardless of the outcome, you are already winners and should feel very proud for putting yourselves out of your comfort zone, for stepping up and taking on the challenge. This is exactly the ethos of our profession.”


PSA extends thanks to the PSOTY award sponsor, Viatris, for their ongoing support and wishes all finalists the best of luck at the national final.


Find out more about the PSA Pharmacy Student of the Year competition by visiting www.psa.org.au/psoty 


Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA partner in PRIDE project, supporting safe and inclusive care for LGBTQIA+ Australians

28 June 2024


The Pharmaceutical Society of Australia (PSA) is proudly partnering with the University of Queensland (UQ) to foster inclusive and empowered primary care workforces through the Promoting queer-inclusive professional identities for diversity in primary healthcare (PRIDE co-design) project.


Funded through the Medical Research Future Fund (MRFF), the PRIDE project aims to make affirming care more accessible through a national network of empowered LGBTQIA+ practitioners and allies, building capacity of the mainstream primary care sector to address the health needs of the LGBTQIA+ community in a safe and inclusive way.


The project will work with a range of peak professional bodies to deliver tailored education to health professionals. As a PRIDE project partner, PSA will offer education and resources to help pharmacists improve the care they provide LGBTQIA+ patients, starting with a session at PSA’s national conference in August.


PSA National President Associate Professor Fei Sim FPS said there is still a long way to go to addressing health inequalities for LGBTQIA+ Australians.


“Everyone has the right to safe, affirming health care,” Associate Professor Sim said.


57% of LGBTQIA+ Australians have reported discrimination due to their sexual orientation, and almost 80% of people who are trans or gender diverse had experienced discrimination due to their gender identity. Stigma and discrimination in the health care context contributes to greater health disparities experienced by LGBTQIA+ communities and can lead to delaying or avoiding healthcare entirely.


“As some of the most accessible health care professionals, pharmacists have a duty of care to patients to ensure that healthcare is provided in a way that is inclusive and appropriate for all people.


“PSA strongly believes in the potential of PRIDE co-design project to have a transformative impact on the development of inclusive and affirming models of care for LGBTQIA+ people experiencing intersectional disadvantage within our health care system.


“We are proud to be working with Dr Ross and her team to provide pharmacists with the resources and training needed to promote truly person-centred care,” A/Prof Sim concluded.


PRIDE Project leader and Chief Investigator Dr Megan Ross highlighted the importance of creating a culture of safe and supportive environments for LGBTQIA+ health practitioners, too.


“Building the capacity of the primary health workforce to deliver safe and affirming care has to include creating safe and inclusive environments for health providers. Too often we see trans and queer practitioners exit the workforce, we need a culture of inclusion that supports LGBTQIA+ practitioners to remain in the workforce and provide safe and affirming care to the community,” Dr Ross said.


“Building multi-disciplinary, connected and trusted network of safe and affirming providers addresses a current gap in primary care.

“A multi-disciplinary affirming provider network will facilitate access to continuous, trustable safe and affirming care across the primary care landscape for LGBTQIA+ consumers, and support LGBTQIA+ practitioners to feel safe and supported in their workplaces.”


Delegates attending PSA24 will have the opportunity to connect with the PRIDE Project during the session Does the pharmacy profession get a rainbow tick? presented by Professor Lisa Nissen and Dr Jean Spinks on Sunday 4 August, 2024.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA Faye McMillan Conference Grant launched for its second year

22 March 2024


“Creating spaces of belonging is a critical component for reconciliation in this country. Grant opportunities such as this allow us to hold this space for others to come into.”

Faye McMillan

The Pharmaceutical Society of Australia (PSA) is proud to launch the PSA Faye McMillan Conference Grant for the second consecutive year, with support from Care Pharmaceuticals and Hydralyte.

Aboriginal & Torres Strait Islander pharmacists and interns are invited to apply for the Conference Grant, named after Wiradjuri yinaa (woman) and trailblazing pharmacist Professor Faye McMillan AM FPS.

Professor Faye McMillan is recognised as the first Indigenous Australian to hold a western degree in pharmacy in this country. She is a 2023/24 Harkness Fellow and a founding member of Indigenous Allied Health Australia, and has received numerous accolades for her leadership and contribution to population health, education, equity and the community. These include PSA Pharmacist of the Year (2022), NSW Aboriginal Woman of the Year (2019), and recognition as a Member of the Order of Australia (AM) for her work in Aboriginal and Torres Strait Islander mental health care and tertiary education.

Faye is a strong advocate for improving Indigenous health care across professions and is driven to help promote the participation and inclusion of Aboriginal and Torres Strait Islander people within pharmacy.

PSA Chief Executive Officer Adjunct Associate Professor Steve Morris says that the Grant is just one way that PSA is promoting pathways for First Nations pharmacists.

“While Aboriginal and Torres Strait Islander peoples comprise 3.8% of Australia’s total population, the current proportion of registered pharmacists who identify as Aboriginal and/or Torres Strait Islander people is much lower at just 0.3%.

“As part of our commitment to supporting and helping increase the representation of Aboriginal and Torres Strait Islander people in pharmacy, this grant opportunity looks to supporting the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.

“PSA continues to proudly support Australia’s First Nations pharmacists, and foster new pathways for the First Nations pharmacists of the future,” Adj. A/Prof Morris says.

Care Pharmaceuticals and Hydralyte Marketing Manager Joan Isaac says that support for First Nations pharmacists is key.

“Care Pharmaceuticals and Hydralyte are excited to partner with PSA for the PSA Faye McMillan Conference Grant. Recognising the significance of inclusivity, we acknowledge the ongoing need to increase participation of Aboriginal and Torres Strait Islander people in pharmacy.

“We hope this grant opportunity represents a genuine commitment to support the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.”​

Expressions of interest for the PSA Faye McMillan Conference Grant are open now. Visit https://www.psa24.com.au/grants for more information.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au